Ours findings that early imaging with FLT rather than FDG predicts later tumor volume is supported by other preclinical studies demonstrating that mTOR-inhibition is better predicted by FLT than FDG in lymphoma cell lines [45] and ovarian cancer cell lines [12]. This evidence concerns the gene MTOR and ovarian carcinoma.